Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | -100,000,000 | -85,000,000 | -111,000,000 | -30,000,000 | -25,000,000 | 10,000,000 | -9,000,000 | -56,000,000 | -14,000,000 | -269,000,000 | 25,000,000 | -14,000,000 | 123,000,000 | 375,000,000 | 16,000,000 | 87,000,000 | 113,000,000 | 77,000,000 | 26,000,000 | 57,000,000 | 902,000,000 | -4,000,000 | 40,000,000 | -5,000,000 | -6,000,000 | -56,000,000 | -30,000,000 | 6,000,000 | 15,000,000 | 50,000,000 | -41,000,000 | 2,000,000 | -241,000,000 | 5,000,000 | -38,000,000 | -42,000,000 | -48,000,000 | -92,000,000 | 217,693,000 | -54,000,000 | -163,954,000 | -46,000 | -90,000,000 | 2,000,000 | -54,000,000 | -3,000,000 | -41,000,000 | -1,000,000 | -45,000,000 | -91,700,000 | -33,500,000 | 1,171,900,000 | 86,300,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation, depletion and amortization | 75,000,000 | 74,000,000 | 71,000,000 | 71,000,000 | 70,000,000 | 72,000,000 | 72,000,000 | 69,000,000 | 67,000,000 | 68,000,000 | 71,000,000 | 68,000,000 | 66,000,000 | 67,000,000 | 68,000,000 | 70,000,000 | 72,000,000 | 71,000,000 | 84,000,000 | 85,000,000 | 76,000,000 | 72,000,000 | 71,000,000 | 75,000,000 | 74,000,000 | 84,000,000 | 47,000,000 | 50,000,000 | 48,000,000 | 49,000,000 | 48,000,000 | 46,000,000 | 13,000,000 | 62,000,000 | 61,000,000 | 60,000,000 | 60,000,000 | 55,000,000 | -221,706,000 | 82,000,000 | 139,935,000 | 65,000 | 68,000,000 | 84,000,000 | 73,000,000 | 95,000,000 | 92,000,000 | 73,000,000 | 73,000,000 | 90,800,000 | 67,300,000 | 30,800,000 | 22,100,000 |
deferred income taxes | 7,000,000 | 3,000,000 | 4,000,000 | 46,000,000 | 18,000,000 | 35,000,000 | 11,000,000 | 16,000,000 | 4,000,000 | 311,000,000 | -1,000,000 | -20,000,000 | -1,000,000 | -244,000,000 | 4,000,000 | 2,000,000 | 11,000,000 | 5,000,000 | -3,000,000 | -2,000,000 | 6,000,000 | -10,000,000 | -3,000,000 | 8,000,000 | 1,000,000 | -33,000,000 | 3,000,000 | -6,000,000 | 6,000,000 | 3,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -1,000,000 | -2,000,000 | -1,997,000 | -3,000 | 32,000,000 | 19,000,000 | 20,000,000 | -9,000,000 | 3,000,000 | -7,900,000 | -45,600,000 | -108,600,000 | 100,000 | |||||||
share-based compensation expense | 5,000,000 | 4,000,000 | 5,000,000 | 4,000,000 | 7,000,000 | 4,000,000 | 6,000,000 | 6,000,000 | 4,000,000 | 5,000,000 | 6,000,000 | 5,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 9,000,000 | 11,000,000 | 8,000,000 | 2,000,000 | 9,000,000 | 8,000,000 | 9,000,000 | 7,000,000 | 8,000,000 | 5,000,000 | 7,000,000 | 2,000,000 | 7,000,000 | 5,000,000 | 4,000,000 | 8,000,000 | 14,000,000 | 9,000,000 | 5,000,000 | 5,000,000 | -16,978,000 | 4,000,000 | 12,994,000 | 6,000 | 5,000,000 | 7,000,000 | 5,000,000 | 1,000,000 | 5,000,000 | 6,000,000 | 5,000,000 | 2,400,000 | |||
amortization of deferred debt issuance costs and discount on debt | 2,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 5,000,000 | 6,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | -7,989,000 | 3,000,000 | 4,998,000 | 2,000 | 2,000,000 | 3,000,000 | 2,000,000 | ||||||||
loss on extinguishment of debt | -2,000,000 | 0 | 0 | 20,000,000 | 1,000,000 | 5,000,000 | 3,000,000 | 23,000,000 | 34,000,000 | 1,000,000 | 0 | 0 | 2,000,000 | 0 | 0 | 0 | 4,000,000 | ||||||||||||||||||||||||||||||||||||
restructuring and other charges | 25,000,000 | 42,000,000 | 86,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash items affecting net income | 14,000,000 | 17,000,000 | 12,000,000 | 11,000,000 | -3,000,000 | 16,000,000 | 8,000,000 | 10,000,000 | 16,000,000 | 29,000,000 | 20,000,000 | 2,000,000 | -1,000,000 | 10,000,000 | 14,000,000 | 14,000,000 | |||||||||||||||||||||||||||||||||||||
changes in assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts receivable, net of allowance for credit losses | -5,000,000 | 30,000,000 | -49,000,000 | 15,000,000 | -3,000,000 | -94,000,000 | 40,000,000 | -41,000,000 | -10,000,000 | -11,000,000 | -120,000,000 | -38,000,000 | |||||||||||||||||||||||||||||||||||||||||
increase in inventories | 3,000,000 | -41,000,000 | -35,000,000 | -104,000,000 | -10,000,000 | -10,000,000 | -48,000,000 | -83,000,000 | -104,000,000 | -71,000,000 | 79,000,000 | 17,000,000 | -10,000,000 | -9,000,000 | -24,000,000 | -5,000,000 | -9,000,000 | 12,000,000 | 12,000,000 | 10,000,000 | 26,000,000 | 12,000,000 | 49,000,000 | 37,000,000 | -89,843,000 | -4,000 | -44,000,000 | -2,000,000 | 4,000,000 | -31,000,000 | 16,000,000 | -5,100,000 | -2,200,000 | -121,500,000 | -93,200,000 | ||||||||||||||||||
decrease in prepaid and other assets | 10,000,000 | 11,000,000 | 18,000,000 | 8,000,000 | 22,000,000 | -6,000,000 | 16,000,000 | 32,000,000 | 11,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
restructuring payments | -30,000,000 | -25,000,000 | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in accounts payable and accrued liabilities | -22,000,000 | -9,000,000 | -49,000,000 | -46,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
net changes in income tax payables and receivables | 3,000,000 | -1,000,000 | -4,000,000 | 2,000,000 | 10,000,000 | 1,000,000 | -3,000,000 | -19,000,000 | -1,000,000 | -6,000,000 | 2,000,000 | -12,000,000 | 15,000,000 | -5,000,000 | 7,000,000 | -5,000,000 | 10,000,000 | -3,000,000 | 7,000,000 | -5,000,000 | 2,000,000 | -8,000,000 | 3,000,000 | -5,000,000 | -3,000,000 | ||||||||||||||||||||||||||||
changes in other non-current assets and liabilities | -19,000,000 | -3,000,000 | -7,000,000 | -6,000,000 | -12,000,000 | -12,000,000 | -8,000,000 | -4,000,000 | -13,000,000 | -9,000,000 | -10,000,000 | 9,000,000 | -17,000,000 | -18,000,000 | -14,000,000 | -24,000,000 | -18,000,000 | -20,000,000 | -16,000,000 | -16,000,000 | -21,000,000 | -14,000,000 | -17,000,000 | -22,000,000 | 3,000,000 | -10,000,000 | -6,000,000 | ||||||||||||||||||||||||||
cash from operating activities | -57,000,000 | 28,000,000 | -32,000,000 | 82,000,000 | 87,000,000 | 160,000,000 | -29,000,000 | 110,000,000 | 17,000,000 | 136,000,000 | -79,000,000 | 240,000,000 | 137,000,000 | 32,000,000 | 189,000,000 | 256,000,000 | 210,000,000 | 135,000,000 | -28,000,000 | 0 | 44,000,000 | -54,000,000 | 39,000,000 | 0 | -30,000,000 | 77,000,000 | 60,000,000 | 54,000,000 | 68,000,000 | 1,000,000 | -44,784,000 | 32,000,000 | 13,065,000 | -65,000 | 54,000,000 | 47,000,000 | -12,000,000 | 127,000,000 | 131,000,000 | 80,000,000 | -1,000,000 | 50,000,000 | 114,500,000 | -20,700,000 | -25,800,000 | ||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | -80,000,000 | -83,000,000 | -110,000,000 | -117,000,000 | -101,000,000 | -76,000,000 | -76,000,000 | -59,000,000 | -54,000,000 | -55,000,000 | -93,000,000 | -114,000,000 | -112,000,000 | -99,000,000 | -103,000,000 | -89,000,000 | -65,000,000 | -60,000,000 | -58,000,000 | -66,000,000 | -47,000,000 | -44,000,000 | -38,000,000 | -58,000,000 | -59,000,000 | -56,000,000 | -25,000,000 | -34,000,000 | -28,000,000 | -27,000,000 | -28,000,000 | -28,000,000 | -7,000,000 | -24,000,000 | -32,000,000 | -32,000,000 | -22,000,000 | -33,000,000 | 140,809,000 | -48,000,000 | -92,968,000 | -32,000 | -39,000,000 | -36,000,000 | -31,000,000 | -68,000,000 | -25,000,000 | -34,000,000 | -45,000,000 | -74,800,000 | -43,700,000 | -26,800,000 | -20,700,000 |
free cash flows | -137,000,000 | -55,000,000 | -142,000,000 | -35,000,000 | -14,000,000 | 84,000,000 | -105,000,000 | 51,000,000 | -37,000,000 | 81,000,000 | -172,000,000 | 126,000,000 | 25,000,000 | -67,000,000 | 86,000,000 | 191,000,000 | 150,000,000 | 77,000,000 | -66,000,000 | -58,000,000 | -15,000,000 | -110,000,000 | 14,000,000 | -28,000,000 | -37,000,000 | 53,000,000 | 28,000,000 | 22,000,000 | 46,000,000 | -32,000,000 | 96,025,000 | -16,000,000 | -79,903,000 | -97,000 | 15,000,000 | 11,000,000 | -43,000,000 | 59,000,000 | 106,000,000 | 46,000,000 | -46,000,000 | -24,800,000 | 70,800,000 | -47,500,000 | -46,500,000 | ||||||||
loans | 0 | 0 | 15,000,000 | -12,000,000 | -12,000,000 | 0 | 0 | 0 | -25,000,000 | -25,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of assets | 1,000,000 | 11,000,000 | 0 | 1,000,000 | 2,000,000 | 2,000,000 | 0 | 1,000,000 | 0 | 0 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||
cash from investing activities | -79,000,000 | -81,000,000 | -95,000,000 | -117,000,000 | -90,000,000 | -60,000,000 | -76,000,000 | -56,000,000 | -54,000,000 | -54,000,000 | -91,000,000 | -104,000,000 | -110,000,000 | -99,000,000 | -102,000,000 | -65,000,000 | -59,000,000 | -57,000,000 | -38,000,000 | 0 | 0 | 49,000,000 | -50,000,000 | 0 | 31,000,000 | -24,000,000 | -32,000,000 | -32,000,000 | -22,000,000 | -32,000,000 | 1,792,160,000 | -48,000,000 | -1,745,368,000 | -632,000 | -39,000,000 | -36,000,000 | -31,000,000 | -67,000,000 | -25,000,000 | -34,000,000 | -45,000,000 | -75,600,000 | -43,700,000 | 88,000,000 | -20,700,000 | ||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of short-term debt | -125,000,000 | -5,000,000 | -6,000,000 | -6,000,000 | -1,000,000 | -5,000,000 | -6,000,000 | -12,000,000 | -86,000,000 | -24,000,000 | -26,000,000 | -89,000,000 | -9,000,000 | -6,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||
repayments of long-term debt | -7,000,000 | -8,000,000 | -6,000,000 | -7,000,000 | -212,000,000 | -4,000,000 | -5,000,000 | -4,000,000 | -4,000,000 | -5,000,000 | -4,000,000 | -5,000,000 | -4,000,000 | -504,000,000 | -3,000,000 | -204,000,000 | -162,000,000 | -586,000,000 | -2,260,000,000 | -210,000,000 | -8,000,000 | -8,000,000 | -7,000,000 | -115,000,000 | -57,000,000 | -114,000,000 | -101,000,000 | -6,000,000 | -5,000,000 | -589,000,000 | -6,000,000 | 0 | |||||||||||||||||||||
proceeds from long-term debt | 5,000,000 | 0 | 0 | 0 | 97,000,000 | 0 | 0 | 2,375,000,000 | 0 | 0 | 0 | 0 | 0 | 222,000,000 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||
proceeds from short-term debt | -103,000,000 | 82,000,000 | 121,000,000 | 5,000,000 | -120,000,000 | 49,000,000 | 152,000,000 | 55,000,000 | 0 | 0 | 0 | -200,000,000 | 213,000,000 | 94,000,000 | |||||||||||||||||||||||||||||||||||||||
proceeds from inventory financing arrangement | |||||||||||||||||||||||||||||||||||||||||||||||||||||
debt issuance costs | -6,000,000 | -2,000,000 | -12,000,000 | 0 | 0 | 0 | -1,000,000 | -2,000,000 | -4,000,000 | -30,000,000 | 0 | -1,000,000 | 0 | 0 | 0 | -4,000,000 | 0 | 0 | -9,000,000 | -1,000,000 | -1,000,000 | 14,985,000 | 0 | 0 | -1,000,000 | 0 | -28,000,000 | ||||||||||||||||||||||||||
dividends paid | -20,000,000 | -19,000,000 | -20,000,000 | -40,000,000 | -1,000,000 | -20,000,000 | -19,000,000 | -48,000,000 | -2,000,000 | -27,000,000 | -19,000,000 | -40,000,000 | -1,000,000 | -19,000,000 | -18,000,000 | -14,000,000 | -14,000,000 | -10,000,000 | -10,000,000 | -10,000,000 | -10,000,000 | -6,000,000 | -7,000,000 | -7,000,000 | -7,000,000 | -6,000,000 | -5,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | -5,000,000 | -6,000,000 | -6,000,000 | -5,000,000 | -5,000,000 | -30,000,000 | 87,883,000 | -29,000,000 | -58,971,000 | -29,000 | -29,000,000 | -29,000,000 | -29,000,000 | -29,000,000 | -29,000,000 | -28,000,000 | -29,000,000 | -29,500,000 | |||||
restricted stock and performance-based shares settled in cash for withholding taxes | 0 | 0 | -1,000,000 | 0 | -1,000,000 | -2,000,000 | 0 | 0 | -3,000,000 | 0 | 0 | -6,000,000 | 0 | -2,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||
cash from financing activities | 189,000,000 | 48,000,000 | 108,000,000 | 26,000,000 | -34,000,000 | -51,000,000 | -12,000,000 | -31,000,000 | 115,000,000 | -28,000,000 | 120,000,000 | -66,000,000 | -41,000,000 | -114,000,000 | -29,000,000 | -179,000,000 | -621,000,000 | 48,000,000 | 193,000,000 | 50,000,000 | -19,000,000 | -12,000,000 | -9,000,000 | -9,000,000 | -49,000,000 | -636,397,000 | -33,000,000 | 669,431,000 | 569,000 | -31,000,000 | -36,000,000 | -33,000,000 | -32,000,000 | -35,000,000 | -29,000,000 | 710,000,000 | -32,600,000 | 514,200,000 | -101,800,000 | 110,200,000 | |||||||||||||
effects of exchange rate changes on cash and cash equivalents and restricted cash | 0 | 0 | 5,000,000 | -2,000,000 | 3,000,000 | -9,000,000 | -1,000,000 | 6,000,000 | -7,000,000 | -6,000,000 | 10,000,000 | -7,000,000 | 4,000,000 | 1,000,000 | 1,000,000 | -9,000,000 | 6,000,000 | -9,000,000 | 2,000,000 | -1,000,000 | -2,000,000 | -6,000,000 | -22,000,000 | 7,000,000 | |||||||||||||||||||||||||||||
net increase in cash and cash equivalents and restricted cash | -16,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents and restricted cash at beginning of period | 0 | 0 | 152,000,000 | 0 | 273,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents and restricted cash at end of period | 53,000,000 | -5,000,000 | 138,000,000 | -16,000,000 | 154,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 55,000,000 | 27,000,000 | 51,000,000 | 22,000,000 | 51,000,000 | 26,000,000 | 52,000,000 | 30,000,000 | 52,000,000 | 27,000,000 | 34,000,000 | 15,000,000 | 39,000,000 | 26,000,000 | 34,000,000 | 44,000,000 | 39,000,000 | 30,000,000 | 17,000,000 | 53,000,000 | 24,000,000 | ||||||||||||||||||||||||||||||||
income taxes paid | -1,000,000 | 1,000,000 | 4,000,000 | -1,000,000 | 0 | 8,000,000 | 3,000,000 | 25,000,000 | 5,000,000 | 17,000,000 | 7,000,000 | 23,000,000 | 4,000,000 | 26,000,000 | 7,000,000 | 5,000,000 | 17,000,000 | 3,000,000 | -4,000,000 | 9,000,000 | 4,000,000 | ||||||||||||||||||||||||||||||||
increase in accounts payable and accrued liabilities | 25,000,000 | -68,000,000 | 50,000,000 | -63,000,000 | -10,000,000 | 18,000,000 | 27,000,000 | 9,000,000 | 15,000,000 | 2,000,000 | -1,000,000 | 34,000,000 | 38,000,000 | -54,000,000 | 61,000,000 | -26,000,000 | 24,000,000 | 8,000,000 | 28,000,000 | -39,000,000 | 29,000,000 | -17,000,000 | -8,000,000 | 34,000,000 | -54,000,000 | 34,988,000 | -36,000,000 | 1,058,000 | -58,000 | -1,000,000 | 17,000,000 | -32,000,000 | 31,000,000 | 7,000,000 | -8,000,000 | -41,000,000 | -129,400,000 | -54,100,000 | 68,900,000 | 7,600,000 | |||||||||||||
net decrease in cash and cash equivalents and restricted cash | -5,000,000 | -14,000,000 | -119,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash affecting net income | 6,000,000 | -8,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in accounts receivable | 19,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of common stock | 0 | -9,000,000 | -16,000,000 | -25,000,000 | 0 | -36,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
call premium paid | -19,000,000 | -21,000,000 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
restricted stock and performance-based shares settled in cash for taxes | -1,000,000 | 0 | -9,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in inventories | -3,000,000 | 11,000,000 | -51,000,000 | -6,000,000 | -17,000,000 | 24,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
effects of exchange rate changes on cash and cash equivalents | -2,000,000 | 1,000,000 | 11,000,000 | -3,000,000 | 4,000,000 | 1,000,000 | 1,000,000 | -1,000,000 | 3,000,000 | 18,974,000 | -11,000,000 | -7,991,000 | -9,000 | -14,000,000 | -3,000,000 | 1,000,000 | -7,000,000 | -3,000,000 | -3,000,000 | -5,000,000 | -200,000 | 3,500,000 | -2,300,000 | 5,000,000 | |||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 79,000,000 | 52,000,000 | -49,000,000 | 58,000,000 | 755,000,000 | 38,000,000 | 17,000,000 | -30,000,000 | -28,000,000 | -75,000,000 | 21,000,000 | 68,000,000 | 14,000,000 | 659,000,000 | -58,400,000 | 588,500,000 | -36,800,000 | 68,700,000 | |||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 164,000,000 | 0 | 0 | 0 | 248,000,000 | 0 | 0 | 229,000,000 | -1,274,724,000 | 0 | 1,274,724,000 | 1,276,000 | 0 | 0 | 1,478,000,000 | 0 | 0 | 0 | 716,000,000 | 0 | 0 | 0 | 154,000,000 | ||||||||||||||||||||||||||||
cash and cash equivalents at end of period | 79,000,000 | 52,000,000 | 115,000,000 | 38,000,000 | 265,000,000 | 14,000,000 | 36,000,000 | 152,000,000 | -144,771,000 | -60,000,000 | 203,861,000 | 1,139,000 | -30,000,000 | -28,000,000 | 1,403,000,000 | 21,000,000 | 68,000,000 | 14,000,000 | 1,375,000,000 | -58,400,000 | 588,500,000 | -36,800,000 | 222,700,000 | ||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance proceeds | 0 | 0 | 0 | 1,000,000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of stock options | |||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in accounts receivable, net of allowance for credit losses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
call premiums paid | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in prepaid and other assets | 7,000,000 | 2,000,000 | 17,000,000 | 8,000,000 | -4,000,000 | 32,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
venator settlement | 85,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable, net of allowance for credit losses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of options | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -23,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 0 | 232,000,000 | 0 | 0 | 648,000,000 | 0 | 0 | 311,000,000 | 0 | 0 | 1,696,000,000 | 0 | 0 | 1,769,000,000 | ||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | -23,000,000 | -182,000,000 | 296,000,000 | 6,000,000 | -460,000,000 | 767,000,000 | 0 | 320,000,000 | 429,000,000 | -90,000,000 | -1,328,000,000 | 1,734,000,000 | |||||||||||||||||||||||||||||||||||||||||
increase in prepaid and other assets | 14,000,000 | -17,000,000 | 9,000,000 | -20,000,000 | -15,000,000 | -3,000,000 | -7,000,000 | -1,000,000 | 26,000,000 | -26,000,000 | -1,000,000 | -12,000,000 | -10,000,000 | -15,000,000 | 9,000,000 | -3,000,000 | -5,000,000 | 3,000,000 | -3,982,000 | 9,000 | -5,000,000 | -2,000,000 | 13,000,000 | -10,000,000 | |||||||||||||||||||||||||||||
decrease in inventories | 21,000,000 | 63,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 64,000,000 | 6,000,000 | -460,000,000 | 119,000,000 | 0 | 320,000,000 | 118,000,000 | -90,000,000 | -1,328,000,000 | 38,000,000 | 44,000,000 | -37,000,000 | -40,000,000 | ||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations, net of tax | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations | 57,000,000 | 902,000,000 | -5,000,000 | -12,000,000 | 6,000,000 | 15,000,000 | 50,000,000 | -41,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income from continuing operations to net cash from operating activities, continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
contract loss | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
acquired inventory step-up recognized in earnings | 3,000,000 | 40,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts receivable | -92,000,000 | 9,000,000 | 9,000,000 | 13,000,000 | -21,000,000 | -1,000,000 | -25,000,000 | -3,000,000 | 13,000,000 | -38,000,000 | 26,000,000 | 36,020,000 | 16,000,000 | -51,975,000 | -25,000 | 60,000,000 | -43,000,000 | -21,000,000 | -13,000,000 | -36,000,000 | 29,700,000 | 62,000,000 | |||||||||||||||||||||||||||||||
cash from operating activities – continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cristal acquisition | 0 | -72,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of ashtabula | -7,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities – continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of noncontrolling interest | 0 | 0 | 0 | -148,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
cash from financing activities – continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from discontinued operations | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents and restricted cash at end of period - continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of warrants and options | -2,997,000 | 0 | 2,997,000 | 3,000 | 3,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
reversal of u.s. valuation allowance | |||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes - other | |||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash items affecting net income from continuing operations | 13,000,000 | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
cash from operating activities - continuing operations | 84,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities - continuing operations | -59,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from financing activities - continuing operations | -26,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash flows used by discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment losses | 6,000,000 | 0 | 25,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
cash from operating activities- continuing operations | 104,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of business | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities- continuing operation | -129,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of options and warrants | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from financing activities- continuing operations | -100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net (loss) from discontinued operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds of short-term debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of warrants | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
corporate reorganization | |||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on extinguishment of debt | 0 | 0 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow information - continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||
pension and postretirement healthcare benefit expense | 1,000,000 | -2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 3,000,000 | 999,000 | 1,000 | 1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||
contributions to employee pension and postretirement plans | -3,000,000 | -6,000,000 | -5,000,000 | -5,000,000 | -7,000,000 | -6,000,000 | -5,000,000 | -11,000,000 | -5,000,000 | -4,000,000 | 15,983,000 | -8,000,000 | -7,997,000 | -3,000 | -8,000,000 | -5,000,000 | -2,000,000 | -1,000,000 | -1,100,000 | ||||||||||||||||||||||||||||||||||
increase in taxes payable | 6,000,000 | -1,000,000 | 2,000,000 | 8,000,000 | 9,000,000 | 11,000,000 | -11,980,000 | 8,000,000 | 4,004,000 | -4,000 | 9,000,000 | 16,000,000 | -7,000,000 | -12,000,000 | -7,000,000 | -6,500,000 | 7,800,000 | -14,600,000 | 15,300,000 | ||||||||||||||||||||||||||||||||||
other | -4,000,000 | -15,000,000 | 11,000,000 | 15,000,000 | 13,000,000 | 2,000,000 | 7,000,000 | 10,000,000 | 11,000,000 | 2,000,000 | -1,004,000 | 0 | 1,001,000 | -1,000 | -2,000,000 | 1,000,000 | -2,000,000 | 23,000,000 | -5,000,000 | -4,000,000 | -5,000,000 | 1,300,000 | 25,200,000 | -23,300,000 | -200,000 | ||||||||||||||||||||||||||||
cash from operating activities, continuing operations | 112,000,000 | 35,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of business | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities, continuing operations | -52,000,000 | -41,000,000 | -28,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
cash from financing activities, continuing operations | -10,000,000 | -9,000,000 | -15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period, continuing operations | 44,000,000 | -37,000,000 | 1,729,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
loan to advanced metal industries cluster company limited | |||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in taxes payable | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
pension and postretirement healthcare benefit income | 1,400,000 | 1,200,000 | 1,100,000 | 1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on extinguishment of debt | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from operating activities-continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
debt proceeds restricted for cristal acquisition | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of business | 1,651,350,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of period - continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from options and warrants | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of period, continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds on sale of assets | 0 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of debt | -4,000,000 | -4,000,000 | -4,000,000 | -4,000,000 | -19,000,000 | 12,982,000 | -4,000,000 | -8,995,000 | -5,000 | -5,000,000 | -6,000,000 | -5,000,000 | -4,000,000 | -5,000,000 | |||||||||||||||||||||||||||||||||||||||
other noncash items affecting net income | 3,000,000 | -5,000,000 | 12,000,000 | -18,000,000 | 14,004,000 | -4,000 | -8,000,000 | 4,000,000 | 8,000,000 | -52,000,000 | -3,000,000 | -12,000,000 | 10,000,000 | 48,700,000 | 90,400,000 | 59,600,000 | 2,300,000 | ||||||||||||||||||||||||||||||||||||
proceeds from debt | -749,250,000 | 0 | 749,400,000 | 600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | 14,000,000 | 36,000,000 | -77,000,000 | -60,000,000 | -1,070,863,000 | -137,000 | |||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | -600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net (gain) loss on liquidation of non-operating subsidiaries | |||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of fair value inventory step-up and unfavorable ore contracts liability | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net income on liquidation of non-operating subsidiaries | |||||||||||||||||||||||||||||||||||||||||||||||||||||
debt issuance costs and commitment fees | -17,700,000 | -200,000 | -1,100,000 | -19,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
gain on bargain purchase | |||||||||||||||||||||||||||||||||||||||||||||||||||||
reorganization items: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
noncash reorganization items | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for reorganization items | |||||||||||||||||||||||||||||||||||||||||||||||||||||
environmental and tort settlement funding | |||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash received in acquisition of minerals sands business | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowings | 0 | 0 | 0 | 945,000,000 | 17,200,000 | 912,700,000 | 227,100,000 | 550,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
merger consideration | -400,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
class a ordinary share repurchases | |||||||||||||||||||||||||||||||||||||||||||||||||||||
class a ordinary shares purchased for the employee participation plan | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from rights offering | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance costs and debt discounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in income taxes payable | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash received in acquisition of minerals sands business, net of cash paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||
class a ordinary share repurchases, including commissions paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||
shares purchased for the employee participation program | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from conversion of warrants | 0 | 0 | 1,000,000 | 400,000 | 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance costs | 1,100,000 | 5,600,000 | 800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
increase in prepaids and other assets | 9,500,000 | 7,900,000 | -1,000,000 | -400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid in acquisition of minerals sands business | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash received in acquisition of minerals sands business | 200,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance costs and discount on debt | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
reductions of debt | -179,000,000 | -2,400,000 | -28,300,000 | -133,200,000 | -421,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit from environmental remediation and restoration, net of reimbursements | |||||||||||||||||||||||||||||||||||||||||||||||||||||
reorganization items | |||||||||||||||||||||||||||||||||||||||||||||||||||||
shares purchased for the employee participation plan | |||||||||||||||||||||||||||||||||||||||||||||||||||||
fees related to rights offering and other related debt costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net income taxes paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on bargain purchase, net of cash received | 15,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
stock compensation expense | 20,500,000 | 6,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
environmental settlement funding | |||||||||||||||||||||||||||||||||||||||||||||||||||||
claims paid with cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||
tort settlement funding | |||||||||||||||||||||||||||||||||||||||||||||||||||||
professional and legal fees | |||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in trade accounts receivable | -77,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in related parties accounts receivable | 5,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in related parties accounts payable | -2,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
other equity | 300,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
